ViiV Healthcare receives EC approval for Apretude to prevent HIV
Cabotegravir is approved for use in combination with safer sex practices as a pre-exposure prophylaxis (PrEP) method and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Sep 23
Cabotegravir is approved for use in combination with safer sex practices as a pre-exposure prophylaxis (PrEP) method and…
19 Sep 23
Under the terms of the new agreement, Samsung Biologics will provide drug substance manufacturing for an antibody cancer…
15 Sep 23
The agreement provides Sun Pharma with rights to commercialise Tyvalzi (Sovateltide) for the treatment of acute cerebral ischemic…
15 Sep 23
The investment is expected to expand Astellas’ capacity and capabilities for aseptic drug products in Ireland, strengthen stable…
15 Sep 23
US-based Generate:Biomedicines will use the funds to advance its portfolio of 17 existing programmes across oncology, immunology, and…
15 Sep 23
Through the collaboration, BeiGene will be granted access to Nona Biosciences' proprietary fully human transgenic mice platform Harbour…
15 Sep 23
Logica, an offering from Charles River and Valo Health, will be used to discover first-in-class therapeutics against high…
14 Sep 23
The Swiss drugmaker will obtain rights to develop and commercialise therapeutic antibodies resulting from the collaboration, while AbCellera…
14 Sep 23
In the trial, the vaccine generated a strong immune response against all four A and B strains of…
14 Sep 23
The companies will work together to promote the Devyser laboratory services to support and advance research and development…